CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


acute kidney injuryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug78 ARFC mask Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D058186 Acute Kidney Injury NIH 0.24

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001919 Acute kidney injury HPO 0.24

There is one clinical trial.

Clinical Trials


1 Acute Kidney Injury In Corona Virus Infection Disease (COVID19) in United Kingdom

Severe Acute respiratory syndrome coronovirus (SARS-CoV-2) was first described in Wuhan in December 2019. It quickly spread to rest of the world and was declared pandemic by World health organisation. Initial case series focused on lung involvement in the form alveolar haemorrhages and respiratory failure. However, subsequently, there have been reports of kidney involvement resulting in severe acute kidney injury. However, the reported incidence from Chinese data has been less than 5% and detailed epidemiology of AKI in COVID-19 disease is lacking.

NCT04407156 COVID AKI Other: acute kidney injury
MeSH:Acute Kidney Injury
HPO:Acute kidney injury

Primary Outcomes

Description: This is the proportion of patients with Acute kidney injury in COVID-19

Measure: Incidence of Acute kidney injury in COVID-19

Time: 7 days

Secondary Outcomes

Description: This is the number of deaths in COVID-19 AKI patients

Measure: All-cause mortality in AKI patients

Time: 7 days


Related HPO nodes (Using clinical trials)